Pharma & Biotech News #PharmaBuzz

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Weekly News Recap #Phispers

Lilly buys biotech Kelonia for up to US$ 7 bn; Trump orders priority review of psychedelic drugs to treat mental illnesses

Eli Lilly has been on an acquisition spree this year. After buying Ventyx Biosciences, Orna Therapeutics, CrossBridge Bio, and...

Impressions : 1326

FDA seeks more safety data from Lilly on obesity drug Foundayo; Novo partners OpenAI to speed up drug development

This week’s Phispers brings you news on how artificial intelligence (AI) is taking centerstage in the world of pharmaceut...

Impressions : 2092

Neurocrine buys Soleno for US$ 2.9 bn; Novo says Wegovy pill outperforms Lilly's Foundayo in cross-trial comparison

In Phispers this week, Neurocrine Biosciences announced the acquisition of rare-disease drugmaker Soleno Therapeutics for US$ ...

Impressions : 1326

Lilly in US$ 7.8 bn deal to acquire Centessa for its sleep disorder pipeline; bags FDA nod for obesity med orforglipron

In Phispers this week, the US Food and Drug Administration (FDA) approved Eli Lilly’s Foundayo (orforglipron), a once-dai...

Impressions : 1176

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

Lilly buys biotech Kelonia for up to US$ 7 bn; Trump orders priority review of psychedelic drugs to treat mental illnesses

FDA seeks more safety data from Lilly on obesity drug Foundayo; Novo partners OpenAI to speed up drug development

Neurocrine buys Soleno for US$ 2.9 bn; Novo says Wegovy pill outperforms Lilly's Foundayo in cross-trial comparison

Lilly in US$ 7.8 bn deal to acquire Centessa for its sleep disorder pipeline; bags FDA nod for obesity med orforglipron

Hainan's Generics Tigecycline Receives Tentative Approval in US

Anthea Pharma's Generics Bupivacaine HCl Receives Approval in US

Shuangcheng's Generics Pantoprazole Na Receives Approval in US

Omsav Pharma's Generics Flecainide Receives Approval in US

Micro's Generics Escitalopram Oxalate Receives Approval in US

Laurus's Generics Valsartan Receives Approval in US

Apotex's Generics Multiple Vitamins Inj Receives Approval in US

Torrent's Generics Vericiguat Receives Tentative Approval in US

Merck Sharp And Dohme's Idvynso Receives Approval in US

Sandoz's Generics Enzalutamide Receives Approval in US

Enforcement Report - Week of April 22, 2026

Veyx-Pharma B.V. Production Fails EDQM Inspection

Produlab Pharma Production Fails EDQM Inspection

Thrive Health and Wellness' Receives FDA Warning Letter

Xiamen Kang Zhongyuan Biotechnology's Receives FDA Warning Letter

Apollo Care's Receives FDA Warning Letter

UCSF Radiopharmaceutical Facility's Receives FDA Warning Letter

RC Outsourcing's Receives FDA Warning Letter

Par Health's Receives FDA Warning Letter

Cabio Biotech Wuhan is on FDA Import Alert List

Vanda Pharma Publishes Imsidolimab GPP Study in NEJM Evidence

Oxford, Serum Institute Ink New Malaria Vaccine Pact

Lighthouse Pharma Closes $12 Million Series A Financing

Revolution Issues Legal Threat to Erasca as Rivalry Heats

Emergent, Substipharm Partner on JE Vaccine Manufacturing

Boehringer, Zealand's Obesity Drug Resembles Novo's Wegovy

AbbVie Seeks FDA Approval for RINVOQ in Severe Alopecia Areata

Tokyo Court To Rule On Fortis Arm IHH And Daiichi Sankyo Dispute

Cumberland Pharma TO Unveil Q1 2026 Financials & Company Update

Nektar To Report Q1 Financial Results On May 7, 2026

Pfizer Secures Deals to Block Heart Drug Generics Until 2030

Hikma And Amarin's Generic Drug Case Goes To Supreme Court

Novartis Reports Earnings Miss Due To Generic Competition

Pfizer Delays Patent Cliff For Blockbuster Vyndamax

Supreme Court to consider skinny labeling case

Alembic Announces FDA Final Approval For Fingolimod Capsules

Sun Pharma signs Definitive Agreement to Acquire Organon

Cipla's generic Ventolin HFA secures USFDA approval

Novartis' Lutathera Radioligand Therapy Faces Generic Rivals

OGD Director Touts Drop In Refuse-To-Receive Determinations

Vanda Pharma Publishes Imsidolimab GPP Study in NEJM Evidence

Oxford, Serum Institute Ink New Malaria Vaccine Pact

Lighthouse Pharma Closes $12 Million Series A Financing

Revolution Issues Legal Threat to Erasca as Rivalry Heats

Emergent, Substipharm Partner on JE Vaccine Manufacturing

Boehringer, Zealand's Obesity Drug Resembles Novo's Wegovy

AbbVie Seeks FDA Approval for RINVOQ in Severe Alopecia Areata

Incyte Claims Double Phase 3 Wins in Vitiligo, Plans NDA Filing

Profluent, Lilly Partner In $2.25B Genetic Medicine Deal

Biomolecular Holdings Issues Foundational Patents

Onco-Innovations Scales Up API Materials for PNKP Program

C-Ray Receives FDA Acceptance of Type2 DMF for Copper-64 (Cu-64)

Akums Launches Aztreonam-Avibactam to Fight Resistant Infections

Chinese API Surge Strains Indian Pharma Amid Mideast Crisis

MiKART, Benuvia Partner for Controlled Drug Solutions

Supriya Lifescience Gets USFDA EIR For Lote Parshuram Site

Rusan Pharma secure Japan PMDA GMP approval for API, FDF facility

Iran War Impact: Essential Drugs May Cost Up To 5% More, For Now

SQ Innovation And FIS Strike Supply Deal For Furosemide API

FDA Accepts NorthStar's DMF for No-Carrier-Added AC-225

FDA Risk Management Biggest Hurdle For Inspections Under QMSR

Gujarat Government Bolsters Drug And Cosmetics Regulation

B. Braun Recalls Lactated Ringer's Injection, 1L

Britain's Lifetime Smoking Ban Set To Become Law

FDA Offers Tips On Verifying, Validating Manufacturing Processes

Probe Urged As Badlapur Fertility Injection Scam Unveiled

Pharma Files Citizen Petition Against Fda Rejection Letters

Citizen Petition Calls On FDA To Tighten Up CRL Disclosures

FDA Addresses Resourcing Issues Amid Rise In 2025 Class I Recalls

Omega Pharma Ltd Recalls Napralief 250Mg Gastro-Resistant Tablets

OMRON Healthcare Donates 3,000 Bp Monitors Worldwide

Cynet Enhances CyAI Engine With Self-Improving Features

VivoSim AI Predicts Diarrhea Risk Without Animal Testing